[HTML][HTML] Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - Elsevier
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic …

TH Terwey, PG Hemmati, M Nagy… - Biology of blood …, 2014 - pubmed.ncbi.nlm.nih.gov
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

[PDF][PDF] Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - 2014 - cyberleninka.org
Few data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic stem cell transplantation. We …

[引用][C] Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - cir.nii.ac.jp
Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction
after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia | CiNii …

Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - infona.pl
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic …

TH Terwey, PG Hemmati, M Nagy… - Biology of Blood and …, 2014 - edoc.mdc-berlin.de
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

[HTML][HTML] Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - astctjournal.org
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

[HTML][HTML] Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute …

TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - tctjournal.org
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic …

TH Terwey, PG Hemmati, M Nagy… - Biology of Blood and …, 2014 - edoc.mdc-berlin.de
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …